140 related articles for article (PubMed ID: 11888291)
1. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface.
Chueh PJ; Kim C; Cho N; Morré DM; Morré DJ
Biochemistry; 2002 Mar; 41(11):3732-41. PubMed ID: 11888291
[TBL] [Abstract][Full Text] [Related]
2. A site-directed mutagenesis analysis of tNOX functional domains.
Chueh PJ; Morré DM; Morré DJ
Biochim Biophys Acta; 2002 Jan; 1594(1):74-83. PubMed ID: 11825610
[TBL] [Abstract][Full Text] [Related]
3. NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms.
Wang S; Pogue R; Morré DM; Morré DJ
Biochim Biophys Acta; 2001 Jun; 1539(3):192-204. PubMed ID: 11420117
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface.
Yantiri F; Morré DJ
Arch Biochem Biophys; 2001 Jul; 391(2):149-59. PubMed ID: 11437345
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (NADH) oxidase.
Jiang Z; Gorenstein NM; Morré DM; Morré DJ
Biochemistry; 2008 Dec; 47(52):14028-38. PubMed ID: 19055324
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface.
Tang X; Tian Z; Chueh PJ; Chen S; Morré DM; Morré DJ
Biochemistry; 2007 Oct; 46(43):12337-46. PubMed ID: 17924659
[TBL] [Abstract][Full Text] [Related]
7. Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion.
Kelker M; Kim C; Chueh PJ; Guimont R; Morré DM; Morré DJ
Biochemistry; 2001 Jun; 40(25):7351-4. PubMed ID: 11412089
[TBL] [Abstract][Full Text] [Related]
8. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.
Chueh PJ; Wu LY; Morré DM; Morré DJ
Biofactors; 2004; 20(4):235-49. PubMed ID: 15706060
[TBL] [Abstract][Full Text] [Related]
9. Surface NADH oxidase of HeLa cells lacks intrinsic membrane binding motifs.
Morré DJ; Sedlak D; Tang X; Chueh PJ; Geng T; Morré DM
Arch Biochem Biophys; 2001 Aug; 392(2):251-6. PubMed ID: 11488599
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin Inhibited Aggressive Phenotypes through Downregulation of Tumor-Associated NADH Oxidase (tNOX) by POU Domain Transcription Factor POU3F2.
Chen HY; Lee YH; Chen HY; Yeh CA; Chueh PJ; Lin YM
Molecules; 2016 Jun; 21(6):. PubMed ID: 27271588
[TBL] [Abstract][Full Text] [Related]
11. Sera from cancer patients contain two oscillating ECTO-NOX activities with different period lengths.
Wang S; Morré DM; Morré DJ
Cancer Lett; 2003 Feb; 190(2):135-41. PubMed ID: 12565167
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients.
Cho N; Chueh PJ; Kim C; Caldwell S; Morré DM; Morré DJ
Cancer Immunol Immunother; 2002 May; 51(3):121-9. PubMed ID: 11941450
[TBL] [Abstract][Full Text] [Related]
13. Catechin-vanilloid synergies with potential clinical applications in cancer.
Morré DM; Morré DJ
Rejuvenation Res; 2006; 9(1):45-55. PubMed ID: 16608395
[TBL] [Abstract][Full Text] [Related]
14. Update on a tumor-associated NADH oxidase in gastric cancer cell growth.
Cheng HL; Lee YH; Yuan TM; Chen SW; Chueh PJ
World J Gastroenterol; 2016 Mar; 22(10):2900-5. PubMed ID: 26973386
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1).
Lin MH; Lee YH; Cheng HL; Chen HY; Jhuang FH; Chueh PJ
Molecules; 2016 Jun; 21(7):. PubMed ID: 27367652
[TBL] [Abstract][Full Text] [Related]
16. ECTO-NOX target for the anticancer isoflavene phenoxodiol.
Morré DJ; Chueh PJ; Yagiz K; Balicki A; Kim C; Morré DM
Oncol Res; 2007; 16(7):299-312. PubMed ID: 17518268
[TBL] [Abstract][Full Text] [Related]
17. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS).
Morré DJ; Morre DM
Mol Cell Biochem; 2006 Feb; 283(1-2):159-67. PubMed ID: 16444599
[TBL] [Abstract][Full Text] [Related]
18. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.
Morré DJ; Wilkinson FE; Kim C; Cho N; Lawrence J; Morré DM; McClure D
Biochim Biophys Acta; 1996 Apr; 1280(2):197-206. PubMed ID: 8639694
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ccapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells.
Wang HM; Chueh PJ; Chang SP; Yang CL; Shao KN
Biofactors; 2008; 34(3):209-17. PubMed ID: 19734122
[TBL] [Abstract][Full Text] [Related]
20. Antisense experiments demonstrate an exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein.
Tang X; Morré DJ; Morré DM
Oncol Res; 2007; 16(12):557-67. PubMed ID: 18351130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
